HAMLET TO4 B — HAMLET Pharma AB Balance Sheet
0.000.00%
Last trade - 00:00
- SEK261.96m
- SEK222.34m
2018 June 30th | 2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | SAS | SAS | SAS | SAS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 15.5 | 10.6 | 13.2 | 7.47 | 39.6 |
Net Total Receivables | 0.422 | 0.485 | 0.754 | 0.496 | 0.847 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 16.2 | 11.2 | 14.5 | 12.7 | 41.7 |
Net Property, Plant And Equipment | 0.396 | 0.081 | 0.045 | 0.009 | 0 |
Total Assets | 16.6 | 11.3 | 14.6 | 12.7 | 41.7 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.77 | 3.25 | 4.08 | 9.99 | 3.72 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 1.77 | 3.25 | 4.08 | 9.99 | 3.72 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 14.8 | 8.03 | 10.5 | 2.75 | 38 |
Total Liabilities & Shareholders' Equity | 16.6 | 11.3 | 14.6 | 12.7 | 41.7 |
Total Common Shares Outstanding |